Use of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure

@inproceedings{Nakagawa2011UseOI,
  title={Use of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure},
  author={Koji Nakagawa and Kazufumi Nakamura and Kengo Kusano and Satoshi Nagase and Takeshi Tada and Masato Murakami and Y. Hata and Hiroshi Morita and Kunihisa Kohno and Kazumasa Hina and Tohru Ujihira and Tohru Ohe and Hiroshi Ito},
  year={2011}
}
Background: Both nifekalant hydrochloride (NIF), a selective IKr blocker, and intravenous amiodarone (AMD), a multi-channel (including IKr blocking) blocker, have been reported to be efficacious for refractory arrhythmias. However, the optimal use of those antiarrhythmic drugs for refractory arrhythmia with severe heart failure has not been established. Intravenous AMD might be effective for arrhythmias refractory to NIF in patients with severe heart failure. Here, we report that intravenous… CONTINUE READING